Loading…
Loading…
Follicular lymphoma is a common indolent B-cell lymphoma that often grows slowly and may be monitored for years.
Quick Answer
Follicular lymphoma is a common indolent B-cell lymphoma that often grows slowly and may be monitored for years. Dr. Sachita Baniya (NMC 20158, 8+ years of clinical experience in haematology and haemato-oncology) evaluates follicular lymphoma at Kathmandu Neurology Clinic & Cognitive Center, 117 Lal Durbar Marg, Kathmandu, Bagmati Province 44600, Nepal — evidence-based, medically reviewed.
Follicular lymphoma usually presents with painless lymphadenopathy and may be discovered incidentally. It is not usually curable with standard therapy but is often controlled for many years. Treatment is reserved for symptomatic, bulky or progressive disease.
Excisional biopsy with immunohistochemistry and grading is preferred. Staging uses imaging, and bone marrow assessment is selective. Transformation should be suspected if the disease behaves aggressively.
Asymptomatic low-burden disease is observed. Treatment options include chemoimmunotherapy, lenalidomide with rituximab and radiotherapy for limited disease. Maintenance rituximab may prolong remission in selected patients.
Management is individualized and discussed with benefits, limitations, and follow-up.
There is no proven prevention. Monitoring for transformation is an important part of follow-up.
Red flags — seek urgent care
Standard treatment is usually not curative, but the disease often responds well and can be controlled for many years. Some patients achieve long remissions.
Treatment is considered for bulky or symptomatic disease, progressive cytopenias, organ compression or rapid growth. Asymptomatic low-burden disease is usually monitored.
Transformation is the development of an aggressive lymphoma from follicular lymphoma. It may present with rapid growth, new symptoms or rising LDH and requires urgent biopsy.
Maintenance rituximab may prolong remission in selected patients after first-line therapy. The benefit and duration are discussed individually.
Some regimens use oral targeted agents, including lenalidomide with rituximab or BTK/BCL2 inhibitors in selected settings. Eligibility depends on the disease and prior treatment.
Radiotherapy can be curative for very limited-stage disease and is also used for local symptoms or residual masses.
Some treatments can affect fertility. Fertility counselling should be part of treatment planning, especially for younger patients.
Follow-up is usually every few months initially, then less often for stable disease. Imaging is used selectively rather than routinely.
Specialist assessment for abnormal blood counts, anaemia, low platelets, bleeding, clotting and suspected blood disorders.
Diagnosis, staging and treatment planning for Hodgkin and non-Hodgkin lymphomas.
Long-term follow-up after blood cancer treatment and transplantation.
Non-Hodgkin lymphoma is a group of lymphoid cancers that includes indolent and aggressive subtypes.
Diffuse large B-cell lymphoma is the most common aggressive lymphoma, typically presenting as a rapidly growing mass.
Mantle cell lymphoma is an aggressive B-cell lymphoma associated with cyclin D1 overexpression and t(11;14).
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.
Reviewed by Dr. Jitendra Prasad Yadav • Last reviewed: 2026-11-10
Content is educational and aligns with standard medical references; individual evaluation may vary. External links provide context and do not imply endorsement.
Doctor — medically reviewed
Dr. Sachita Baniya
Consultant Haemato-Oncologist & Clinical Hematologist • MBBS, FCPS (Clinical Haematology) • NMC 20158
This condition guide was medically reviewed by Dr. Sachita Baniya.
On this site
Article information
Emergency
For sudden neurologic change, thunderclap headache, or seizure >5 min, seek emergency services now.